For people with knee arthritis and type 2 diabetes, taking GLP-1 drugs (like Ozempic) may lower the chance of needing knee surgery — and about one-third of that benefit comes from losing weight, not just from better blood sugar control.

67

Pro

0

Against

Evidence from Studies

Supporting (1)

67

Community contributions welcome

67

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Cohort Study

Human

2023 Sep

The study found that diabetes medication (GLP-1RAs) lowers the chance of needing knee surgery in people with knee arthritis and diabetes, and about one-third of that benefit comes from weight loss.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Score: 67

DOI: 10.1136/ard-2023-223845

Similar Assertions

People with knee arthritis and diabetes who take GLP-1 drugs like Ozempic seem to need knee surgery less often — 1.7% of them did over 6 years, compared to 5.9% who didn’t take the drugs — and some of this benefit comes from losing weight.

0

8

91%

People with knee arthritis and type 2 diabetes who take GLP-1 drugs (like Ozempic) may be less likely to need knee surgery—only 1.7% did, compared to 5.9% who didn’t take the drugs, over about 8 years.

67

0

87%

People with knee arthritis and type 2 diabetes who took GLP-1 drugs for nearly 5 years had slower knee cartilage loss, even after accounting for weight loss or blood sugar changes — meaning these drugs might actually be helping protect the joints.

26

0

86%

People with knee arthritis and type 2 diabetes who take GLP-1 drugs like semaglutide tend to lose a lot more weight—about 7 extra kilograms—over nearly 8 years compared to those not taking them, and many more of them achieve meaningful weight loss.

67

0

86%

People with knee arthritis and type 2 diabetes who take GLP-1 drugs like Ozempic might lose knee cartilage more slowly, which could help delay joint damage.

67

0

85%